FOURKITES
22.5.2023 18:36:28 CEST | Business Wire | Press release
Leading real-time supply chain visibility company FourKites today announces that, for the third consecutive year, it has been named a Leader in the 2023 Gartner® Magic Quadrant™ for Real-Time Transportation Visibility Platforms* (RTTVPs). Gartner evaluated nine vendors for its report, and FourKites received its position as a Leader both for its Ability to Execute and Completeness of Vision.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230522005540/en/
FourKites Named a Leader in the 2023 Gartner® Magic Quadrant™ for Third Consecutive Year. (Photo: Business Wire)
FourKites, the largest global visibility solution, tracks over 3 million shipments per day across all modes and connects the global supply chains of 50% of the Fortune 500, including customers in Europe such as Barilla, Henkel, Bayer, Dow, Volvo Group, cargonerds, Spotos and Bacardi. In 2022, FourKites achieved a 70% YoY growth in global customers — totalling over 1,200 — nearly 50% growth in total shipments and 37% growth in connected facilities, the latter of which now total over 3.2 million individual facilities around the world. In Europe specifically, FourKites saw 2X growth in shipments, across 120 countries and territories; 40% growth in European customers; 24% growth in the number of carriers tracking shipments; and nearly 3 billion miles tracked in the region.
“2022 was a year of tremendous growth and acceleration of our business,” said FourKites CEO and founder Mathew Elenjickal. “In addition to growing our shipper and carrier base around the world, we have forged strategic partnerships with industry titans, grown our C-suite with seasoned executives, and continued to innovate with our customers to add meaningful business value to their most critical pain points. We’re proud to be recognised as a Leader yet again by Gartner.”
What Customers Are Saying on Gartner Peer Insights™
FourKites continues to earn accolades for its unique customer-driven innovation model; for the maturity of its end-to-end, multimodal platform; and for its unwavering commitment to customer success.
“Supply chain management has become so much easier now. Gratification arises from knowing that our cargo has been safely delivered, because FourKites allows our team to keep track of exactly where it is. Having access to the data and analytics that FourKites has supplied has been necessary for decision-making, controlling the items exiting our facility, and efficiently monitoring shipments.”
Global Mobility Project Manager, UK, Finance
“As a solution provider, FourKites provides a remarkable coverage and support experience. They are an accelerator of our digital transformation initiatives and a great partner who pro-actively seeks feedback in order to gleam future needs and innovations to their roadmap.”
Global Futurist, UK, Software Industry
“To serve our customers, we need a platform that enables supply chain professionals to act quickly to fulfill their orders. Making decisions, regulating what leaves our facilities, and effectively tracking shipments have all required access to the data and analytics that FourKites has provided. The user interface is relatively simple and adaptable to the needs of each individual user, which makes it quite easy to use. … As the product has been so successful in the US, we want to expand it to our offices and affiliates abroad to take advantage of its popularity.”
VP of Supply Chain, Services (non-Government) Industry
“Working with FourKites has been great. They are constantly innovating and bringing new features or products to the table. They are also great at listening to customer feedback, ensuring the new features or upgrades align with customer needs.”
Transportation Systems Analyst, Consumer Goods Industry
“FourKites is bringing visibility that our supply chain has never had before. The notifications for delivery, real-time predictive ETAs are game changers for efficiency and the aggregate data provided by FourKites unlocks control tower capability.”
Director Domestic Transportation, Retail
“FourKites’ platform is complete and mature from an ocean, rail and truck tracking perspective, but they offer so much more when you start to look at their Yard Management and Appointment Scheduling tools. Their onboarding and customer success teams are professional and helpful. They are our partners in this ongoing journey.”
Supply Chain Professional, Retail
FourKites Leads Industry Innovation to Deliver Unprecedented Value
FourKites pioneered the real-time transportation visibility (RTTV) category in 2014 and was the first company to extend real-time visibility across supply chains end-to-end, from yards to warehouses and more. In addition to strategic investments in 2021 from industry heavyweights Qualcomm Ventures, LLC, Volvo Group Venture Capital AB and Zebra Technologies, FourKites recently has inked strategic alliances with Mitsui & Co., Ltd., FedEx, Quiet Platforms, Sony, Microsoft and Narvar. In addition, FourKites has been recognised for its industry leadership and innovation by SupplyChainBrain, Blue Yonder, Builtin Chicago, Manhattan Associates, and it is one of only four Transportation and Logistics companies to receive Inc.’s Best in Business Award.
Recent FourKites innovations include Sustainability Hub, which provides supply chain leaders with advanced emissions tracking and reporting capabilities; Data Connector, which accelerates time-to-insights by allows customers to automatically access and leverage FourKites data directly within their existing business intelligence tools; and FourKites Connect, which accelerates the carrier connectivity process from hours or even days to just minutes.
*Gartner, Magic Quadrant for Real-Time Transportation Visibility Platforms, Carly West, Oscar Sanchez Duran, Nathan Lease, 16 May 2023.
Gartner Disclaimer:
Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organisation and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
GARTNER is a registered trademark and service mark, and Magic Quadrant and PEER INSIGHTS is a registered trademark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved. Gartner Peer Insights content consists of the opinions of individual end users based on their own experiences, and should not be construed as statements of fact, nor do they represent the views of Gartner or its affiliates. Gartner does not endorse any vendor, product or service depicted in this content nor makes any warranties, expressed or implied, with respect to this content, about its accuracy or completeness, including any warranties of merchantability or fitness for a particular purpose.
About FourKites
Leading global supply chain visibility platform FourKites® extends visibility beyond transportation into yards, warehouses, stores and beyond. Tracking more than 3 million shipments daily across road, rail, ocean, air, parcel and last mile, and reaching over 200 countries and territories, FourKites combines real-time data and powerful machine learning to help companies digitise their end-to-end supply chains. More than 1,200 of the world’s most recognised brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit https://www.fourkites.com/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230522005540/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom